Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Menorrhagia 1Leiomyoma 1Carcinoma, Renal Cell 1Adenocarcinoma 1

Interventions

estradiol, norethindrone drug combination 7asoprisnil 6relugolix 5Estradiol 5elagolix 4vilaprisan 3Norethindrone Acetate 3linzagolix 2Uterine Artery Embolization 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Hysterectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Menorrhagia × Medroxyprogesterone Acetate × Clear all
NCT06671548 2026-02-02

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Qilu Pharmaceutical Co., Ltd.

Phase 3 Recruiting
120 enrolled

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡